Euphorigenic doses of cocaine reduce [I-123]beta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts

被引:45
作者
Malison, RT
Best, SE
Wallace, EA
McCance, E
Laruelle, M
Zoghbi, SS
Baldwin, RM
Seibyl, JS
Hoffer, PB
Price, LH
Kosten, TR
Innis, RB
机构
[1] YALE UNIV,SCH MED,DEPT PSYCHIAT,NEW HAVEN,CT 06520
[2] YALE UNIV,SCH MED,DEPT DIAGNOST RADIOL,NEW HAVEN,CT 06520
[3] YALE UNIV,SCH MED,DEPT VET AFFAIRS MED CTR,NEW HAVEN,CT 06520
[4] EMORY UNIV,SCH MED,DEPT PSYCHIAT,ATLANTA,GA 30322
关键词
I-123]beta-CIT; dopamine transporter; cocaine; medication development;
D O I
10.1007/BF02246266
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The in vivo potency of euphorigenic doses of intravenous cocaine for displacing [I-123]beta-CIT ([I-123]2 beta- carbomethoxy-3 beta-(4-iodophenyl)tropane) binding to striatal dopamine transporters (DAT) was assessed in human cocaine addicts using single photon emission computed tomography (SPECT). Cocaine-dependent subjects (n = 6) were injected with [I-123]beta-CIT and imaged 24 h later under equilibrium conditions. Sequential cocaine infusions (0.28 +/- 0.03 and 0.56 +/- 0.07 mg/kg) produced significant (P < 0.0005) reductions in the specific to non-specific equilibrium partition coefficient, V-3 '' (6 +/- 6 and 17 +/- 3%), a measure proportional to DAT binding potential. Regression analysis of the legit transformed data enabled reliable determination of the Hill coefficient (0.51) and 50% displacement (ED(50)) dose of cocaine (2.8 mg/kg). These preliminary data suggest that cocaine produces behavioral effects in humans at measurable levels of DAT occupancy.
引用
收藏
页码:358 / 362
页数:5
相关论文
共 20 条
[1]  
BAXTER LR, 1988, J CLIN PSYCHIAT, V49, P23
[2]   [I-125] RTI-55 - A POTENT LIGAND FOR DOPAMINE TRANSPORTERS [J].
BOJA, JW ;
PATEL, A ;
CARROLL, FI ;
RAHMAN, MA ;
PHILIP, A ;
LEWIN, AH ;
KOPAJTIC, TA ;
KUHAR, MJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 194 (01) :133-134
[3]   KINETICS OF COCAINE DISTRIBUTION, ELIMINATION, AND CHRONOTROPIC EFFECTS [J].
CHOW, MJ ;
AMBRE, JJ ;
RUO, TI ;
ATKINSON, AJ ;
BOWSHER, DJ ;
FISCHMAN, MW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (03) :318-324
[4]   PROTEIN-BINDING OF COCAINE IN HUMAN-SERUM [J].
EDWARDS, DJ ;
BOWLES, SK .
PHARMACEUTICAL RESEARCH, 1988, 5 (07) :440-442
[5]   PET STUDY OF [C-11] BETA-CIT BINDING TO MONOAMINE TRANSPORTERS IN THE MONKEY AND HUMAN BRAIN [J].
FARDE, L ;
HALLDIN, C ;
MULLER, L ;
SUHARA, T ;
KARLSSON, P ;
HALL, H .
SYNAPSE, 1994, 16 (02) :93-103
[6]   MAPPING COCAINE BINDING-SITES IN HUMAN AND BABOON BRAIN INVIVO [J].
FOWLER, JS ;
VOLKOW, ND ;
WOLF, AP ;
DEWEY, SL ;
SCHLYER, DJ ;
MACGREGOR, RR ;
HITZEMANN, R ;
LOGAN, J ;
BENDRIEM, B ;
GATLEY, SJ ;
CHRISTMAN, D .
SYNAPSE, 1989, 4 (04) :371-377
[7]  
HOLMAN BL, 1991, J NUCL MED, V32, P1206
[8]   CELLULAR AND MOLECULAR MECHANISMS OF DRUG-DEPENDENCE [J].
KOOB, GF ;
BLOOM, FE .
SCIENCE, 1988, 242 (4879) :715-723
[9]   THE DOPAMINE HYPOTHESIS OF THE REINFORCING PROPERTIES OF COCAINE [J].
KUHAR, MJ ;
RITZ, MC ;
BOJA, JW .
TRENDS IN NEUROSCIENCES, 1991, 14 (07) :299-302
[10]   SPECT IMAGING OF DOPAMINE AND SEROTONIN TRANSPORTERS WITH [I-123] BETA-CIT - PHARMACOLOGICAL CHARACTERIZATION OF BRAIN UPTAKE IN NONHUMAN-PRIMATES [J].
LARUELLE, M ;
BALDWIN, RM ;
MALISON, RT ;
ZEAPONCE, Y ;
ZOGHBI, SS ;
ALTIKRITI, MS ;
SYBIRSKA, EH ;
ZIMMERMANN, RC ;
WISNIEWSKI, G ;
NEUMEYER, JL ;
MILIUS, RA ;
WANG, SY ;
SMITH, EO ;
ROTH, RH ;
CHARNEY, DS ;
HOFFER, PB ;
INNIS, RB .
SYNAPSE, 1993, 13 (04) :295-309